13D Filing: Avego Healthcare Capital, LLC and Acer Therapeutics Inc. (ACER)

Page 7 of 12

Page 7 of 12 – SEC Filing


CUSIP No.
00444P108
1. Names of Reporting Persons.
Christopher R. Manning
2. Check the Appropriate Box if a
Member of a Group (See Instructions)
(a) [   ]
(b) [   ]
3. SEC Use Only
4. Source of Funds (See
Instructions)
AF
5. Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) [   ]
6. Citizenship or Place of
Organization
United States of America
Number of 7. Sole Voting Power
Shares 0
Beneficially
Owned by 8. Shared Voting Power
Each          527,983
Reporting
Person 9. Sole Dispositive Power
With 0
10. Shared Dispositive Power
         527,983
11. Aggregate Amount Beneficially
Owned by Each Reporting Person
527,983
12. Check if the Aggregate Amount in
Row (11) Excludes Certain Shares (See Instructions) [   ]
13. Percent of Class Represented by
Amount in Row (11)
8.18%
14. Type of Reporting Person (See
Instructions)
IN HC

7

Follow Acer Therapeutics Inc. (NASDAQ:ACER)

Page 7 of 12